Wolfson Group, a global consumer wellness company, announced today the acquisition of a portfolio of established wellness brands, including PhenQ, TestoPrime, NooCube, and YourBiology. The move is designed to strengthen the company's position in the rapidly growing health and wellness sector while accelerating expansion across the United States.
The acquired brands are already available to U.S. consumers through Amazon, with Wolfson Group now investing in broader market expansion through additional retail partnerships, enhanced consumer education, strategic distribution, and continued product innovation. The portfolio spans several of the fastest-growing areas of consumer wellness, including weight management, cognitive performance, gut health, healthy ageing, and men's wellbeing. Together, the brands serve consumers looking for science-led products that support long-term health and lifestyle goals.
"The acquisition represents an exciting milestone in our long-term growth strategy," said Scott Dingwall, Founder and CEO of Wolfson Group. "These brands have built strong customer loyalty and proven demand across key wellness categories. By bringing them into the Wolfson Group family, we can accelerate investment, expand distribution, and make these trusted products accessible to even more consumers across the United States."
The acquisition reflects Wolfson Group's commitment to building a diversified wellness ecosystem focused on preventative health and evidence-based nutrition. The company believes continued consumer demand for proactive wellness solutions presents significant opportunities for long-term growth in North America. "We continue to see consumers taking greater ownership of their health and wellbeing," Dingwall added. "Our ambition is to build brands that people trust throughout every stage of their wellness journey. This acquisition gives us an even stronger foundation to deliver on that vision."
For industry leaders, this acquisition signals a consolidation trend in the wellness market, where scale and multi-brand strategies become critical to capturing consumer loyalty and shelf space. Wolfson Group's expanded portfolio positions it to compete more effectively with larger players by leveraging a combined customer base and cross-selling opportunities. The focus on evidence-based products may also raise the bar for competitors, as consumers increasingly demand scientific validation for wellness claims.
Wolfson Group plans to continue investing in product innovation, digital growth, retail partnerships, and international expansion as it scales the portfolio across the U.S. market. The company's strategy underscores the importance of integrating e-commerce with traditional retail to maximize reach, a lesson for other businesses in the sector.
